Business Unit: HR Operations

Client: Julie-Ann Leblanc

HR Operations Experience Design team brought on several change management and communications consultants to support various phases of the HR Service Delivery Optimization initiative over 18 months. Through Expertise On Demand, the client was able to quickly access user experience, change management, and process improvement expertise as the project moved forward.

Business Unit: PBG / Vaccines

Client: Flavio Frei

Vaccines global commercial franchise developing strategy had limited visibility into military market and requested an assessment on global military & policy landscape. The team engaged a former Deloitte consultant with a background working as a national security analyst for the Middle East and direct experience working with Army RFPs.

Project scope included competitive landscape analysis, narrowing of markets & assessment of business environments, and strategic recommendations that helped shape the franchise strategy.

Business Unit: PBG / Oncology

Client: Monika Smith

At the U.S. biosimilars portfolio team prepared for two upcoming launches (new indication and new formulation) over six months in 2021, the team needed additional bandiwdth to meet the timelines for the launches. The team quickly engaged aan experienced pharma consultant who directly supported the portfolio director with strategic planning, tactical pull-through, agency/vendor oversight and management, ad hoc strategic support for the portfolio.

Business Unit: PBG / HBU

Client: Duke Doshi

Two consultants with prior SCIg launch experience supported the U.S. Cutaquig team with go-to-market strategy development and launch activities

Scope included GTM strategy development, creation of brand strategic plan and tactics promotional material creation/review, market research assessment, KOL & advocacy group engagement; consultants provided guidance on product portfolio and lifecycle management as needed

Business Unit: PBG / Rare Disease

Client: David Norris

With multiple upcoming gene therapy launches, the Rare Disease New Product Planning team needed a consultant to help further develop a detailed launch plan and establish a PMO for gene therapy launches. The team engaged a consultant who had supported another project at Pfizer and was able to quickly ramp within RD.

The consultant created a standardized launch platform to be used for multiple therapies in the portfolio, operationalized the launch plan with detailed execution steps, and provided ongoing PMO support.

Business Unit: PBG / Oncology

Client: Kathleen Keenoy

U.S. Oncology brand team was looking for a consultant to conduct a promotional sensitivity analysis to help inform the appropriate level of investment/promotion in 2021.
Scope included developing approaches to evaluate how the current promotional activities align with strategic priorities and identifying drivers of new prescription vs volume growth vs share growth

A small firm of former ZS consultants created a master database at HCP level with promotions over time; deliverables included profiling HCPs based on promotional activities and evaluation of the impact of various promotional activities on sales and share

Business Unit: PBG / Vaccines

Client: Tony Sarraino

Commercial development team was revisiting the strategic framework developed by BCG that had guided the thinking over the past few years. The team was looking for a consultant to revise the strategy, review strategic initiatives that were underway, and consider new initiatives for the next 3-5 years.

The team engaged a former BCG consultant with direct experience working with large amounts of market data/knowledge to create strategies based on customized frameworks.

Business Unit: P&HI / Real World Evidence

Client: Lauren Becnel

The Real World Evidence Oncology team was undergoing an organization-wide effort to adapt to rapidly evolving RWE environment and needed a strategic project manager to engage with a cross-functional group of internal stakeholders. Through Expertise On Demand, the team brought on pharmaceutical strategy consultant to organize the newly formed committee and drive towards an aligned RWD strategy. The consultant created project charter, governance team & process, strategy development, communications and reporting, and evaluated ~25 external companies as potential partners, leading to one equity investment and several multi-year development partnerships.

Over the next 24 months, the Global RWE lead engaged two program/alliance managers to oversee various strategic projects as the group scales. This included assessing potential partnerships, new data and tool rollouts, process design, and partnership governance support. The team also engaged a Business Analyst to support the Program Managers, business partners, and internal committees, as well as a Technical Trainer to work with the technical partners, understand data and tools provided to deliver training to Pfizer colleagues